Medication delivery device maker adds Ver-ID for biometric patient verification

AceAge, the maker of a home health appliance designed to help people take their medication safely, has selected Applied Recognition’s face recognition technology to make its ‘Karie’ device more secure and user-friendly.

Ver-ID is Applied Recognition’s line of software development kits that make it easy to add face recognition capabilities to digital business processes. According to the announcement, Ver-ID technology is distinctive in achieving high levels of accuracy and speed while able to run entirely on mobile devices as well as in the cloud, enabling the use of face recognition in applications where biometric-enablement would otherwise be impractical.

“It was a natural decision to add Applied Recognition’s technology to our flagship product,” explained Spencer Waugh, CEO of AceAge. “Now, our end users can dispense their prescriptions at a glance and without worry that, for example, a child might inadvertently get access. Our partners understand that better adherence will both lower healthcare costs and improve health outcomes, as well as bring security to medication in people’s homes.”

AceAge anticipates that adding face recognition is going to contribute to making Karie a must-have for management of late-stage clinical trials where strong documentation of adherence is essential. The face recognition feature will also allow users to digitally sign electronic medication adherence records.

Set to be commercially available later this year, Karie schedules, monitors and delivers medication for its users, enabling older individuals to age in place and relieving caregivers from the task of medication management.

“We’re proud that Ver-ID will be used to help people improve their health outcomes,” said Ray Ganong, Applied Recognition’s Co-CEO. “Karie fixes the very real problem of drug non-adherence and does so elegantly.”

Article Topics

Applied Recognition  |  biometrics  |  facial recognition  |  patient identification